• COMPASSプロジェクト
  • MENU
  • COMPASSプロジェクト TOP

  • Patient Centered Careアプローチ研修
  • Patient Centered Careアプローチ研修 研修日程 申込
  • RxING Registry-Japan研究とは
  • お問い合わせ
  • What is COMPASS project?
  • A collaborative research project for pharmacy practice in five countries


  • COMPASS stands for Community Pharmacists Association for Diabetes patients
  • intervention study in Japan.We named our intervention study and other research
  • projects as COMPASS projectbecause we hope our research show community pharmacists
  • the proper course in the future.
  • COMPASS-1 study was done in 2013. This is the first randomized control trial (RCT)
  • at a community pharmacy setting in Japan. This study report got the best poster
  • award from the FIP 2012. (FIP: International Pharmaceutical Federetion)
  • Now we are doing new RCT: COMPASS-BP and COMPASS-SMBG. COMPASS-BP is for
  • hypertension and COMPASS-SMBG is for diabetes. In both studies, community
  • pharmacists support patients using motivational interviewing skills and
  • advice giving. We'll also begin a new international research project in 2015
  • about pharmacists'new role and chronic disease management in community pharmacies.
・Researcher at Kyoto Medical Center
・A member of the overseas committee in the Japan
Pharmaceutical Association (JPA)
・An Executive Committee member of the Social
and Administrative Pharmacy Section (SAPS) of the
International Pharmaceutical Federation (FIP)

He got his bachelor in pharmaceutical science from
Nagasaki University and in Education from Fukuoka
University Education. He also got Master degree in Science from Kyoto University. When he was working as a community pharmacist, he realized the importance of a communicative and supportive relationship between pharmacists and patients. Very few studies have been done in Japan, he began researching the different approaches of how pharmacists communicate with their patients and the effects it has on them. He named this the COMPASS (Community Pharmacists Association for Diabetes patients intervention study in Japan) Project’ which are cluster randomized controlled trials in community pharmacies for patients with chronic disease. The COMPASS-1 study validated my hypothesis that patients with diabetes could see improvements in their blood glucose levels based on short motivational interviews conducted by their community pharmacists. This study report received the best poster award at the FIP 2012 conference. Now he is conducting COMPASS-BP for patients with hypertension and COMPASS-SMBG for patients with diabetes in 70 community pharmacies. His research group is trying to change the role of community pharmacists and their relationship with their patients.
HOME >> COMPASS project